Research Paper Volume 12, Issue 20 pp 20753—20777

Substance P blocks ovariectomy-induced bone loss by modulating inflammation and potentiating stem cell function

class="figure-viewer-img"

SP can restore impaired function of BMSC due to osteoporosis. (A) Experimental scheme for direct actions of SP on BMSC in vitro. (B) Cell viability was measured by WST-1 assay. (C) Population doubling time (PDT) of BMSC was calculated. (D) p-Akt, t-Akt, p-Erk and t-Erk protein levels were determined by western blot and their expression levels were quantified using the Image J program, relative to the GAPDH. (E) Osteogenic differentiation was exerted by BMSCs and determined by alizarin red staining. (F) TGF-β1, OPG and HGF protein expressions in BMSC were elucidated by western blots and quantified relatively. p values of less than 0.05 were considered statistically significant (* p <0.05, ** p <0.01, *** p <0.001). The data are expressed as the mean ± standard deviation (SD) of three independent experiments. OPG: osteoprotegerin, HGF: hepatocyte growth factor. n = 5/ experimental setting.